'Substantia nigra' diaporamas de présentation

Prevention of Alcohol and Other Drug Problems What We Can Do!

1.39k views • 113 slides

Movement Disorders

Movement Disorders. Tory Davis PA-C UNE PA Program. Tremor Classification. Rest vs Action Body part(s) affected Frequency- how fast, measured in hertz (cycles/second) Amplitude- fine or coarse. Resting Tremor.

1.64k views • 97 slides

968 views • 55 slides

Demonstrate an understanding of main connections and functions of the basal ganglia

Demonstrate an understanding of main connections and functions of the basal ganglia. TE 4.2. Basal ganglia. The basal ganglia are paired groups of forebrain nuclei found deep within the cerebral hemispheres that help to control movement.

790 views • 52 slides

Procedural Sedation in the Pre-Hospital Setting

Procedural Sedation in the Pre-Hospital Setting. Antoinette Eng, MD Albany Medical Center December 20, 2006. EMS Procedural Sedation: Overview. Definition Indications Medications Recent Research Summary. Sedation. Controlled reduction of environmental awareness. Sedation. Dynamic.

1.17k views • 51 slides

Extrapyramidal diseases

Extrapyramidal diseases. ?.Formation of basal ganglia. * Corpus striatum:/caudate nucleus neostriatum lentiform/putamen nucleus / nucleusglobus pallidus- paleostriatum * Red nucleus * Substantia nigra * Subthalamic nucleus.

889 views • 37 slides

Basal Ganglia Principles of neural sciences 5 th ed.

Basal Ganglia Principles of neural sciences 5 th ed. The human brain: an introduction to its functional anatomy 6 th ed. ? ? ? ?????? ??????. Basal ganglia and surrounding structures, as seen in an axial section. Basal ganglia and surrounding structures, as seen in coronal sections.

637 views • 35 slides

Common neurological conditions and their risk factors

508 views • 32 slides

Introduction to the Nervous system

471 views • 31 slides

Pharmacologic Management of Parkinsonism & Other Movement Disorders, Chapter 28

Pharmacologic Management of Parkinsonism & Other Movement Disorders, Chapter 28. OBJECTIVES Describe the neurochemical imbalance underlying the symptoms of Parkinson's disease.

638 views • 27 slides

Neurologic Disorders of the Larynx and Videostroboscopy

Neurologic Disorders of the Larynx and Videostroboscopy. Stephanie Cordes, MD Anna Pou, MD April 1998. Introduction. scientific and technological advancements improvements in diagnosis of voice disorders better understanding of laryngeal function

1.01k views • 25 slides

Neurologic Disorders of the Larynx and Videostroboscopy

Neurologic Disorders of the Larynx and Videostroboscopy. Stephanie Cordes, MD Anna Pou, MD April 1998. Introduction. scientific and technological advancements improvements in diagnosis of voice disorders better understanding of laryngeal function

552 views • 25 slides

conventional antipsychotic drug

M1. 1. H1. conventional antipsychotic drug. D2. Stahl S M, Essential Psychopharmacology (2000). 11-7. Stahl S M, Essential Psychopharmacology (2000). 11-2. pure D2 blocker. Mesocortical pathway. Increase in negative symptoms. Stahl S M, Essential Psychopharmacology (2000). 11-3.

447 views • 21 slides

Carlson (7e) Chapter 8: Control of Movement

Carlson (7e) Chapter 8: Control of Movement. Skeletal Muscle. Movements of our body are accomplished by contraction of the skeletal muscles Flexion : contraction of a flexor muscle draws in a limb Extension : contraction of extensor muscle Skeletal muscle fibers have a striated appearance

583 views • 20 slides

341 views • 20 slides

BRAIN DAMAGE AND HUMAN NEUROPSYCHOLOGICAL DISEASES

626 views • 19 slides

Basal Ganglia

Basal Ganglia. I . Centers II. Afferent/Efferent Connections III. Function IV. Pathophysiology of Basal Ganglia Syndromes. I. General Organization: Centers.

1.07k views • 17 slides

Neurology and Rehabilitation Target Day 24-11-04

349 views • 16 slides

Imaging the brainstem at 1.5 and 4.0 T

Imaging the brainstem at 1.5 and 4.0 T. Elena Manova. Who am I ?. Carrier goals:. Knowledge!!! Application of SWI in revealing the reason for and occurrence of Alzheimer's disease Optimizing sequences for imaging the brainstem at 1.5 and 4.0 T Molecular imaging.

195 views • 7 slides

STN

243 views • 2 slides